Cochrane Abstracts
Second‐line systemic therapy for metastatic colorectal cancer
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Second‐line Systemic Therapy for Metastatic Colorectal Cancer." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/435593/all/Second‐line_systemic_therapy_for_metastatic_colorectal_cancer.
Second‐line systemic therapy for metastatic colorectal cancer. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/435593/all/Second‐line_systemic_therapy_for_metastatic_colorectal_cancer. Accessed December 5, 2025.
Second‐line systemic therapy for metastatic colorectal cancer. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/435593/all/Second‐line_systemic_therapy_for_metastatic_colorectal_cancer
Second‐line Systemic Therapy for Metastatic Colorectal Cancer [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 December 05]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/435593/all/Second‐line_systemic_therapy_for_metastatic_colorectal_cancer.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Second‐line systemic therapy for metastatic colorectal cancer
ID - 435593
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/435593/all/Second‐line_systemic_therapy_for_metastatic_colorectal_cancer
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
